Exodus Point Capital Management, LP Nkarta, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$3.37 - $6.3 $93,028 - $173,911	27,605 Added 25.3%	136,700 $485,000
Q4 2022 Feb 13, 2023	BUY	$5.14 - $14.35 $224,612 - $627,080	43,699 Added 66.82%	109,095 $653,000
Q3 2022 Nov 10, 2022	SELL	$12.27 - $18.39 $3.26 Million - $4.89 Million	-266,069 Reduced 80.27%	65,396 $861,000
Q2 2022 Aug 19, 2022	BUY	$7.77 - $19.44 $2.58 Million - $6.44 Million	331,465 New	331,465 $4.08 Million
Q1 2022 May 13, 2022	SELL	$8.66 - $14.99 $291,616 - $504,773	-33,674 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$12.79 - $26.88 $19,965 - $41,959	-1,561 Reduced 4.43%	33,674 $517,000
Q3 2021 Nov 15, 2021	BUY	$26.67 - $38.76 $757,774 - $1.1 Million	28,413 Added 416.49%	35,235 $980,000
Q2 2021 Aug 16, 2021	BUY	$23.94 - $36.68 $163,318 - $250,230	6,822 New	6,822 $216,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.